期刊文献+

铜绿假单胞菌耐药机制研究进展 被引量:27

Research Progress of Resistance Mechanisms of Pseudomonas Aeruginosa
下载PDF
导出
摘要 铜绿假单胞菌是临床常见的条件致病菌。随着抗生素广泛应用和不合理使用导致细菌抗生素耐药性增加,临床已分离到大量多重耐药菌株,给临床治疗带来极大的困难。铜绿假单胞菌耐药机制十分复杂,该文就外膜通透性障碍、作用靶位改变、产生灭活酶、形成生物膜和主动外排泵系统等耐药机制做一综述。 Pseudomomas aeruginosa is a common clinical conditioned pathogens. The extensive and irrational use of antimicrobial agents ,makes the resistance of Pseudomonas aeruginosa becoming stronger. There has been a lot of multidrug resistant strains which makes the clinical treatment great difficult. Resistance mechanisms of Pseudonumas aeruginosa is very complex. This review summarized the resistance mechanisms of the barrier of outer membrane permeability,the change of action targets ,the formation of inactivated enzyme ,the formation of biofilm and active efflux pump system.
出处 《现代检验医学杂志》 CAS 2011年第3期91-95,共5页 Journal of Modern Laboratory Medicine
基金 基金项目:本研究受国家自然科学基金资助(项目编号:81071397).
关键词 铜绿假单胞菌 耐药机制 Β-内酰胺酶 生物膜 主动外排泵 Pseudomonas aeruginosa resistance mechanisms β-lactamases biofilmactive efflux pump
  • 相关文献

参考文献20

  • 1Delcour AH. Outer membrane permeability and an- tibiotic resistance [J]. Biochim Biophys Aeta, 2009, 1794(5) : 808-816.
  • 2Nikaido H. Molecular basis of bacterial outer mem- brane permeability revisited [J]. Microbiol Mol Biol Rev, 2003,67 (4) : 593-656.
  • 3Farra A, Islam S, Stralfors A, et al. Role of outer membrane protein OprD and penicillin-binding pro-teins in resistance of Pseudomonas aeruginosa to imipenem and meropenem[J]. Int J Antimierob A- gents, 2008,31 (5) : 427-433.
  • 4Giske CG,Buaro L,Sundsfjord A,et al. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseu- domonas aeruginosa[J]. Microb Drug Resist (Larch- mont ,NY), 2008,14 (1) : 23-30.
  • 5Kwon DH,Lu CD. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone an- tibiotics in Pseudomonas aeruginosa PAO1 [J]. An- timicrob Agents Chemother, 2006, 50 (5): 1615- 1622.
  • 6Akasaka T ,Tanaka M, Yaumguchi A, et al. Type II topoisomerase mutations in fluoroquinoone-resis- tant clinical strains of Pseudomonas aeruginosa iso- lated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance[J]. Antimi- crob Agents Chemother, 2001,45 (8) : 2263-2268.
  • 7Strateva T, Yordanov D. Pseudomonas aeruginosa-a phenomenon of bacterial resistanee[J]. J Med Micro- biol, 2009,58 (Ptg): 1133-1148.
  • 8David M, Lemeland JF, Boyer S. Emergence of ex- tended-spectrum beta-lactamases in Pseudomonas aeruginosatabout 24 cases at Rouen University Hos- pital [J]. Pathol Biol (Paris), 2008, 56 (7-8): 429- 434.
  • 9Poirel L, Brinas L, Verlinde A, et al. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta- lactamase, and the class 1 integron In120 in Pseu- domonas aeruginosa [ J ]. Antimicrob Agents Chemother,2005,49 (9) : 3743-3848.
  • 10Giuliani F, Docluier JD, Riccio ML, et al. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM -1-containing inte- gron from a Pseudomonas aeruginosa clinical isolate [J]. Antimicrob Agents Chemother, 2005, 49 (5) .. 1973-1980.

同被引文献313

引证文献27

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部